- Home
- GDEN vs CRMD Comparison
GDEN vs CRMD Comparison
Compare GDEN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEN | CRMD |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | 504 | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 763.2M | 626.0M |
| IPO Year | 1998 | 2009 |
Fundamental Metrics
Financial Performance| Metric | GDEN | CRMD |
|---|---|---|
| Price | $28.59 | $8.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $32.25 | $14.83 |
| AVG Volume (30 Days) | ★ 2.4M | 1.4M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $634,911,000.00 | $311,709,000.00 |
| Revenue This Year | $5.17 | $0.30 |
| Revenue Next Year | $2.87 | N/A |
| P/E Ratio | ★ N/A | $19.44 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $19.57 | $6.13 |
| 52 Week High | $32.74 | $17.43 |
Technical Indicators
Market Signals| Indicator | GDEN | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.46 | 57.89 |
| Support Level | $28.30 | $6.14 |
| Resistance Level | $28.78 | $8.53 |
| Average True Range (ATR) | 0.37 | 0.28 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 74.93 | 66.06 |
Price Performance
Historical ComparisonAbout GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.